inhibitors of FLT-3, Aurora-1, Aurora-2, and Aurora-3 protein kinases; leukemia; N-{4-[4-(5-Methyl-2H-pyrazol-3-ylmethyl)-6-(4-propyl-piperazin-1-yl)-pyrim- idin-2-ylsulfanyl]-phenyl}-propionamide


Ontology type: sgo:Patent     


Patent Info

DATE

2009-07-07T00:00

AUTHORS

CHARRIER JEAN-DAMIEN , MAZZEI FRANCESCA , KAY DAVID , MILLER ANDREW

ABSTRACT

The present invention provides a facile process for the preparation of tri- and tetra-substituted pyrimidines. The process is useful for preparing inhibitors of protein kinases, especially Aurora kinase. These inhibitors are useful for treating or lessening the severity of Aurora-mediated diseases or conditions.

Related SciGraph Publications

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/34", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3404", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "name": "CHARRIER JEAN-DAMIEN", 
        "type": "Person"
      }, 
      {
        "name": "MAZZEI FRANCESCA", 
        "type": "Person"
      }, 
      {
        "name": "KAY DAVID", 
        "type": "Person"
      }, 
      {
        "name": "MILLER ANDREW", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/357161a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022093620", 
          "https://doi.org/10.1038/357161a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/35096075", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049241198", 
          "https://doi.org/10.1038/35096075"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/343651a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015375932", 
          "https://doi.org/10.1038/343651a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/35048096", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051541099", 
          "https://doi.org/10.1038/35048096"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm1003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014550555", 
          "https://doi.org/10.1038/nm1003"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1385/jmn:19:3:275", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016328080", 
          "https://doi.org/10.1385/jmn:19:3:275"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2009-07-07T00:00", 
    "description": "

The present invention provides a facile process for the preparation of tri- and tetra-substituted pyrimidines. The process is useful for preparing inhibitors of protein kinases, especially Aurora kinase. These inhibitors are useful for treating or lessening the severity of Aurora-mediated diseases or conditions.

", "endDate": "2023-12-12", "id": "sg:patent.US-7557106-B2", "name": "inhibitors of FLT-3, Aurora-1, Aurora-2, and Aurora-3 protein kinases; leukemia; N-{4-[4-(5-Methyl-2H-pyrazol-3-ylmethyl)-6-(4-propyl-piperazin-1-yl)-pyrim- idin-2-ylsulfanyl]-phenyl}-propionamide", "recipient": [ { "id": "http://www.grid.ac/institutes/grid.422219.e", "type": "Organization" } ], "sameAs": [ "https://app.dimensions.ai/details/patent/US-7557106-B2" ], "sdDataset": "patents", "sdDatePublished": "2022-11-24T21:23", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/patent/patent_52.jsonl", "type": "Patent" } ]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/patent.US-7557106-B2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/patent.US-7557106-B2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/patent.US-7557106-B2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/patent.US-7557106-B2'


 

This table displays all metadata directly associated to this object as RDF triples.

62 TRIPLES      15 PREDICATES      22 URIs      9 LITERALS      2 BLANK NODES

Subject Predicate Object
1 sg:patent.US-7557106-B2 schema:about anzsrc-for:34
2 anzsrc-for:3404
3 schema:author Nb358e5a99d7d4a0587ed6742bc6ff527
4 schema:citation sg:pub.10.1038/343651a0
5 sg:pub.10.1038/35048096
6 sg:pub.10.1038/35096075
7 sg:pub.10.1038/357161a0
8 sg:pub.10.1038/nm1003
9 sg:pub.10.1385/jmn:19:3:275
10 schema:datePublished 2009-07-07T00:00
11 schema:description <p num="p-0001">The present invention provides a facile process for the preparation of tri- and tetra-substituted pyrimidines. The process is useful for preparing inhibitors of protein kinases, especially Aurora kinase. These inhibitors are useful for treating or lessening the severity of Aurora-mediated diseases or conditions.</p>
12 schema:endDate 2023-12-12
13 schema:name inhibitors of FLT-3, Aurora-1, Aurora-2, and Aurora-3 protein kinases; leukemia; N-{4-[4-(5-Methyl-2H-pyrazol-3-ylmethyl)-6-(4-propyl-piperazin-1-yl)-pyrim- idin-2-ylsulfanyl]-phenyl}-propionamide
14 schema:recipient grid-institutes:grid.422219.e
15 schema:sameAs https://app.dimensions.ai/details/patent/US-7557106-B2
16 schema:sdDatePublished 2022-11-24T21:23
17 schema:sdLicense https://scigraph.springernature.com/explorer/license/
18 schema:sdPublisher N723451a209b9474595f77a9c8f4c1559
19 sgo:license sg:explorer/license/
20 sgo:sdDataset patents
21 rdf:type sgo:Patent
22 N1c3ccc07df4c4f4c967bcac242687b59 schema:name KAY DAVID
23 rdf:type schema:Person
24 N45b3a02394914edeb2be122034b85fc7 rdf:first N1c3ccc07df4c4f4c967bcac242687b59
25 rdf:rest Ne9443a9e1ac44af1b811ed141d988dde
26 N5b02371fb00846fd89600e65f5e6a2b7 rdf:first N77f6c62989cc43a8b74861b59b9ac763
27 rdf:rest N45b3a02394914edeb2be122034b85fc7
28 N723451a209b9474595f77a9c8f4c1559 schema:name Springer Nature - SN SciGraph project
29 rdf:type schema:Organization
30 N77f6c62989cc43a8b74861b59b9ac763 schema:name MAZZEI FRANCESCA
31 rdf:type schema:Person
32 Nb358e5a99d7d4a0587ed6742bc6ff527 rdf:first Nf15cb769ca6d4f4f84f41c2d845b4b00
33 rdf:rest N5b02371fb00846fd89600e65f5e6a2b7
34 Nc7f265ebd85d426b8c9229641ba02dcc schema:name MILLER ANDREW
35 rdf:type schema:Person
36 Ne9443a9e1ac44af1b811ed141d988dde rdf:first Nc7f265ebd85d426b8c9229641ba02dcc
37 rdf:rest rdf:nil
38 Nf15cb769ca6d4f4f84f41c2d845b4b00 schema:name CHARRIER JEAN-DAMIEN
39 rdf:type schema:Person
40 anzsrc-for:34 schema:inDefinedTermSet anzsrc-for:
41 rdf:type schema:DefinedTerm
42 anzsrc-for:3404 schema:inDefinedTermSet anzsrc-for:
43 rdf:type schema:DefinedTerm
44 sg:pub.10.1038/343651a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015375932
45 https://doi.org/10.1038/343651a0
46 rdf:type schema:CreativeWork
47 sg:pub.10.1038/35048096 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051541099
48 https://doi.org/10.1038/35048096
49 rdf:type schema:CreativeWork
50 sg:pub.10.1038/35096075 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049241198
51 https://doi.org/10.1038/35096075
52 rdf:type schema:CreativeWork
53 sg:pub.10.1038/357161a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022093620
54 https://doi.org/10.1038/357161a0
55 rdf:type schema:CreativeWork
56 sg:pub.10.1038/nm1003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014550555
57 https://doi.org/10.1038/nm1003
58 rdf:type schema:CreativeWork
59 sg:pub.10.1385/jmn:19:3:275 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016328080
60 https://doi.org/10.1385/jmn:19:3:275
61 rdf:type schema:CreativeWork
62 grid-institutes:grid.422219.e schema:Organization
 




Preview window. Press ESC to close (or click here)


...